Monitoring the Effect of Heparin Bolus during Percutaneous Coronary Angioplasty (PTCA): Assessment of Three Bedside Coagulation Monitors

• References

• 1 Grill HP, Spero JE, Granato JE. Comparison of activated partial thromboplastin time to activated clotting time for adequancy of heparin anticoagulation just before percutaneous coronary angioplasty. Am J Cardiol 1993; 71: 1219-20.
• 2 Rath B, Bennet DH. Monitoring the effect of heparin by measurement of activated clotting time during and after transluminal coronary angioplasty. Br Heart J 1990; 63: 18-21.
• 3 Narins CR, Hillegass WB, Nelson CL, Tcheng JE, Harrington RA, Phillips HR, Stack RS, Califf RM. Relation between activated clotting time during angioplasty and abrupt closure. Circulation 1996; 93: 667-71.
• 4 Avendano A, Fergusson JJ. Comparison of Hemochron and HemoTec activated coagulation time target values during percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1994; 23: 907-10.
• 5 Metz D, Urban P, Hoang V, Camenzind E, Chatelain P, Meier B. Predicting ischemic complications after bailout stenting following failed coronary angioplasty. Am J Cardiol 1994; 74: 271-4.
• 6 The EPILOG investigators.. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revacularization. N Engl J Med 1998; 336: 1689-96.
• 7 Indices of reproducibility. In: Methods in observational epidemiology. Kelsey JL, Thompson WD, Evans AS. eds. Oxford University Press; 1986. 10 288-92.
• 8 The APTT monitoring of heparin. The ISTH/ICSH collaborative study. Van der Velde EA, Poller L. Thromb Hemost 1995; 73: 73-81.